Home › Trial NCT02298816
B-Cell Hematologic Malignancy Vaccination Registry
- Trial IDNCT02298816
- StatusWithdrawn
- PhaseN/A
- Study typeObservational
- SponsorWake Forest University Health Sciences
- Enrollment—
- Start date2014-08
- ConditionsMonoclonal Gammopathy of Undetermined Significance · Multiple Myeloma · Waldenstrom Macroglobulinemia · Lymphocytosis · Lymphoma, Non-Hodgkin · B-Cell Chronic Lymphocytic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.